Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.662,03
1,23%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC Axim Biotechnologies Inc (QB) (AXIM) Axim Biotechnologies Inc (QB) (AXIM) Notizie

AXIM

Axim Biotechnologies (QB) (AXIM)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:AXIM
DataOraFonteTitoloSimboloCompagnia
28/12/202317:59Edgar (US Regulatory)Form 8-K - Current reportUSOTC:AXIMAxim Biotechnologies Inc (QB)
20/11/202322:29Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:AXIMAxim Biotechnologies Inc (QB)
21/09/202317:07Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsUSOTC:AXIMAxim Biotechnologies Inc (QB)
31/08/202322:10Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsUSOTC:AXIMAxim Biotechnologies Inc (QB)
14/08/202322:11Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:AXIMAxim Biotechnologies Inc (QB)
12/06/202312:43Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:AXIMAxim Biotechnologies Inc (QB)
30/05/202321:51Edgar (US Regulatory)Current Report Filing (8-k)USOTC:AXIMAxim Biotechnologies Inc (QB)
22/05/202323:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:AXIMAxim Biotechnologies Inc (QB)
17/04/202322:46Edgar (US Regulatory)Annual Report (10-k)USOTC:AXIMAxim Biotechnologies Inc (QB)
31/03/202312:04Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:AXIMAxim Biotechnologies Inc (QB)
07/10/202221:28Edgar (US Regulatory)Report of Proposed Sale of Securities (144)USOTC:AXIMAxim Biotechnologies Inc (QB)
24/09/202200:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:AXIMAxim Biotechnologies Inc (QB)
23/09/202222:08Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:AXIMAxim Biotechnologies Inc (QB)
23/09/202222:06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:AXIMAxim Biotechnologies Inc (QB)
31/08/202222:08Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:AXIMAxim Biotechnologies Inc (QB)
16/08/202212:07Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:AXIMAxim Biotechnologies Inc (QB)
02/08/202212:07Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:AXIMAxim Biotechnologies Inc (QB)
25/07/202213:12Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:AXIMAxim Biotechnologies Inc (QB)
19/04/202223:26Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:AXIMAxim Biotechnologies Inc (QB)
02/06/202112:01Edgar (US Regulatory)Amended Quarterly Report (10-q/a)USOTC:AXIMAxim Biotechnologies Inc (QB)
17/12/201912:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:AXIMAxim Biotechnologies Inc (QB)
13/09/201814:45InvestorWireThe CBD Bonanza on the HorizonUSOTC:AXIMAxim Biotechnologies Inc (QB)
21/05/201812:21Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:AXIMAxim Biotechnologies Inc (QB)
13/12/201714:45InvestorWireDangerous Opioid Side Effects Shift Market Focus to Cannabis for Chronic PainUSOTC:AXIMAxim Biotechnologies Inc (QB)
06/12/201714:45InvestorWireAdvanced Biosynthesis Setting New Standards for Cannabinoid-based Pain ManagementUSOTC:AXIMAxim Biotechnologies Inc (QB)
07/11/201714:45InvestorWireBiotech M&A Momentum Attractive for Cannabinoid R&D SpaceUSOTC:AXIMAxim Biotechnologies Inc (QB)
25/10/201714:45InvestorWireBiotechs Develop Proprietary Systems to Drive CBD Research and DevelopmentUSOTC:AXIMAxim Biotechnologies Inc (QB)
28/09/201714:45InvestorWireCannabinoid Biosynthesis Poised as Potential Game-Changer in Drug DevelopmentUSOTC:AXIMAxim Biotechnologies Inc (QB)
26/09/201714:45InvestorWireMedical Cannabis Companies Leverage Biosynthesis to Boost Drug DevelopmentUSOTC:AXIMAxim Biotechnologies Inc (QB)
13/09/201714:45InvestorWireBiosynthesis Technology Could Transform Cannabinoid ProductionUSOTC:AXIMAxim Biotechnologies Inc (QB)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:AXIM

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
TIT
Telecom Italia
BIT
SPM
Saipem
BIT
SRG
Snam
BIT
TEN
Tenaris
BIT
TRN
Terna Trasmissione Elett...
BIT
IVG
Iveco Group NV
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network